• Chaoju Eye Care (2219) updated its board and committee lineup in a filing dated Aug. 28, 2026.
• Chairman Zhang Bozhou remains the sole named chairman in the document, serving as executive director.
• Independent directors lead key oversight roles: Li Jianbin chairs the audit committee; Bao Shan chairs the remuneration committee.
• Zhang Bozhou chairs the nomination committee, chairs the ESG committee, holds a seat on the remuneration committee.
• Other committee seats include Guo Hongyan on audit, He Mingguang on nomination, Bao Shan on audit, nomination, ESG.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chaoju Eye Care Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260828-12303970), on August 28, 2026, and is solely responsible for the information contained therein.